NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Target Corporation (NYSE: TGT) between August 26, 2022 and November 19, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 1, 2025. SO WHAT: If you purchased Target common stock during the Class Period you may be entitled to compensation without payment of any out of

Perforator An example of a flame graph generated by Perforator. Yandex introduces Perforator, a tool that can identify and evaluate code inefficiencies across a company’s entire code base. Perforator helps developers identify the most resource-intensive sections of code and provides detailed statistics for subsequent optimization. The solution can help businesses reduce CPU resource usage by 20% annually. By leveraging Perforator, companies can potentially save millions or even billions, depending on company size, and allocate resources for further innovation and growth. Perforator can be accessed for free on GitHub. DUBAI, United Arab Emirates, Feb. 05, 2025 (GLOBE NEWSWIRE) — Yandex, a global

(L to R): Alpha Bravo Navigation Backpack in Red/Lime Chameleon, Voyageur Celina Backpack in Denim Blue HONG KONG SAR – Media OutReach Newswire – 5 February 2025 – TUMI, the leading international travel, lifestyle and accessories brand, is ushering in Spring 2025 with vibrant energy. This season marks a significant milestone—TUMI’s 50th anniversary—celebrating a legacy rich in heritage, innovation and enduring performance. From exceptional craftsmanship to groundbreaking advancements, TUMI symbolizes timeless luxury. For Spring 2025, TUMI seamlessly blends ancient and modern influences, highlighting the allure and vibrancy of Peru, the birthplace of the brand. This collection reflects the brand’s commitment to

– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Trial in Relapsing Multiple Sclerosis (MoonStone) expected in third quarter 2025- -Topline results from pivotal Phase 3 Trial in Immunoglobulin G4-Related Disease (INDIGO) expected year-end 2025- – Enrollment of Phase 2 Trial in Systemic Lupus Erythematosus (SunStone) expected to be completed in 2025- – Out-licensed greater-China anti-IGF-1R Thyroid Eye Disease programs to Zai Lab – WALTHAM, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global

BitMEX Launches 20 New Altcoin Options Traders can now access a total of 26 altcoin options contracts for Litecoin, Sui, Chainlink, Aave, and more on BitMEX Traders can now access 20 new altcoin options contracts for Litecoin, Sui, Chainlink, Aave, and more on BitMEX MAHE, Seychelles, Feb. 05, 2025 (GLOBE NEWSWIRE) — BitMEX, the OG crypto derivatives exchange, is excited to announce the launch of 20 new option contracts, offering traders one of the first-ever opportunities to engage with a diverse range of altcoin options across Litecoin (LTC), SUI (Sui), LINK (Chainlink), AAVE (Aave), and more. BitMEX Options delivers on deep liquidity